Clinical Trial: Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children

U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07798232) titled 'Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children' on Aug. 24.

Brief Summary: This study will look at whether children ages 5-8 who take Penicillin V by mouth twice a day are less likely to develop rheumatic heart disease (RHD) over a 3-year period compared to children who do not take the medicine.

Study Start Date: Feb. 01, 2027

Study Type: INTERVENTIONAL

Condition: Rheumatic Heart Disease in Children

Intervention: DRUG: Oral Penicillin V

Twice-daily oral Pen V 250 mg

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Children's Hospital Medical Center, Cincinnati

Disclaimer: Curated by HT Syndicati...